Trigeminal Neuralgia: Literature Review

The trigeminal nerve, fifth equal of cranial nerves, a mixed nerve is considered by possessing motor and sensitive components. The sensitive portion takes to the Nervous System Central somesthesics information from the skin and mucous membrane of great area of the face, being responsible also for a neural disease, known as the Trigeminal Neuralgia. The aim of this study was to review the literature on the main characteristics of Trigeminal Neuralgia, the relevant aspects for the diagnosis and treatment options for this pathology. This neuralgia is characterized by hard pains and sudden, similar to electric discharges, with duration between a few seconds to two minutes, in the trigeminal nerve sensorial distribution. The pain is unchained by light touches in specific points in the skin of the face or for movements of the facial muscles, it can be caused by traumatic sequels or physiologic processes degenerative associate the vascular compression. Prevails in the senior population, frequently in the woman. In a unilateral way it attacks more the maxillary and mandibular divisions, rarely happens in a simultaneous way in the three branches of trigeminal nerve three branches.30115Adams, R.D., Victor, M., (1985) Principles of Neurology, , New York: Mc Graw-Hill Book CompanyBayer, D.B., Stenger, T.G., Trigeminal Neuralgia: An overview (1979) Oral Surgery, 48 (5), pp. 393-399. , http://dx.doi.org/10.1016/0030-4220(79)90064-1Bennetto, L., Patel, N.K., Fuller, G., (2007) Trigeminal Neuralgia and Its Management, 334, pp. 201-205. , http://dx.doi.org/10.1136/bmj.39085.614792.BE, BMJ, PMid:17255614 PMCid:1782012Brow, J.A., Percutaneous balloon compression for trigeminal Neuralgia (2009) Clinical Neurosurgery, 56, pp. 73-76. , PMid:20214036Eskandar, E., Barker, F.G., Rabinov, J.D., Case records of the Massachusetts General Hospital. Case21-2006. A61-year-old man with left-sided facial pain (2006) New England Journal of Medicine, 355, pp. 183-188. , http://dx.doi.org/10.1056/NEJMcpc069011, PMid:16837683Fardy, M.J., Patton, D.W., Complication associated with peripheral alcohol injections in the management of trigeminal neuralgia (1994) British Journal of Oral and Maxillofacial Surgery, 32 (6), pp. 387-391. , http://dx.doi.org/10.1016/0266-4356(94)90031-0Frizzo, H.M., Hasse, P.N., Veronese, R.M., Neuralgia do Trigêmeo: Revisão Bibliográfica Analítica (2004) Revista De Cirurgia E Traumatologia Buco-Maxilo-Facial, 4 (4), pp. 212-217Galassi, C., Blasi, G., Galassi, G., Serra, M., Faverio, A., Nevralgie trigeminali ed altre algie del capo (1985) Parodontologia E Stomatologia (nuova), 2, pp. 45-160Goto, F., Ishizaki, K., Yoshikawa, D., Obata, H., Arii, H., Terada, M., The long lasting effects of peripheral nerve blocks for trigeminal neuralgia using a high concentration of tetracaine dissolved in bupivacaine (1999) Pain, 79, pp. 101-103. , http://dx.doi.org/10.1016/S0304-3959(98)00156-0Gusmão, S., Magaldi, M., Arantes, A., Rizotomia trigeminal por radiofrequência para tratamento da neuralgia do trigêmeo: Resultados e modificação técnica (2003) Arquivos De Neuro-Psiquiatria, 61 (2), pp. 434-440. , http://dx.doi.org/10.1590/S0004-282X2003000300020, PMid:12894280Hotta, T.H., Bataglion, A., Bataglion, C., Bezzon, O.L., Involvemente of dental occlusion and trigeminal neuralgia: A clinical report (1997) Journal of Prosthetic Dentistry, 77 (4), pp. 343-345. , http://dx.doi.org/10.1016/S0022-3913(97)70155-0Jacob, R.P., Rhoton, J.A.L., Diagnosis and Nonoperative Management of Trigeminal Neuralgia (1996) In: YOUMANS, JR. Neurological Surgery, 5, pp. 3376-3385. , 4th Ed. W. B. Saunders CompanyJanneta, P.G., Gross (Mesoscopic) description of the human trigeminal nerve and ganglion (1963) Journal of Neurosurgery, 20, pp. 109-111Katusic, S., Beard, M.B., Bergstralh, E., Kurland, L.T., Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota:1945-1984 (1990) Annals of Neurology, 27, pp. 89-95. , http://dx.doi.org/10.1002/ana.410270114, PMid:2301931Krafft, R.M., Trigeminal neuralgia (2008) American Family Physician, 77, pp. 1291-1296. , PMid:18540495Linskey, M.E., Jho, H.D., Jannetta, P.J., Microvascular decompression for trigeminal neuralgia caused by vertebrobasilar compression (1994) Journal of Neurosurgery, 81, pp. 1-9. , http://dx.doi.org/10.3171/jns.1994.81.1.0001, PMid:8207508Loh, H.S., Ling, S.Y., Shanmuhasuntharam, P., Zain, R., Yeo, J.F., Khoo, S.P., Trigeminal neuralgia. A retrospective survey of a sample of patients in Singapore and Malaysia (1998) Australian Dental Journal, 43 (3), pp. 188-191. , PMid:9707784Luna, E.B., Graça, L.F.A., Silva, D.C.O., Bérzin, F., Silva, Z., Souza, G.C., Mitri, F.F., Aspectos Anatômicos e Patológicos da Neuralgia do Trigêmeo: Uma revisão da literatura para estudantes e profissionais da saúde (2010) Bioscience Journal, 26 (4), pp. 661-674Maestri, J.M., Holzer, F., Fisiopatología de la neuralgia del trigémeno (1993) Revista Chilena De Neuro-Psiquiatria, 31 (3), pp. 317-321Mattos, J.M.B., Bueno, F.V., Mattos, L.R., Neuralgia do Trigêmeo: Um novo protocolo de tratamento clínico (2005) Revista Dor, 6 (4), pp. 652-656Meneses, M.S., Clemente, R., Russ, H.H., Traitement microchirurgical de la névralgie du trijumeau (1995) Neurochirurgie, 41 (5), pp. 349-352. , PMid:8577355Monzillo, P.H., Sanvito, W.L., Costa, A.R., Cluster-Tic, S., Syndrome: Report of five new cases (2000) Arquivos De Neuro-Psiquiatria, 58, pp. 518-521. , http://dx.doi.org/10.1590/S0004-282X2000000300019, PMid:10920416Neville, B.W., Damm, D.D., Allen, C.M., Bouquot, J.E., (2004) Patologia Oral E Maxilofacial.2.ed, pp. 865-867. , Rio de Janeiro: Guanabara KooganNurmikko, T.J., Eldridge, P.R., (2001) Trigeminal Neuralgia: Pathophysiology, Diagnosis and Current Treatment. BJA: British Journal of Anaesthesia, 87, pp. 117-132. , http://dx.doi.org/10.1093/bja/87.1.117Patterson, C.W., Trigeminal neuralgia-a dental diagnosis challenge (1999) Northwest Dentistry, 78 (3), pp. 19-24Peters, G., Nurmikko, T.J., Peripheral and gasserian ganglion-level precedures for the treatment of trigeminal neuralgia (2002) Clinical Journal of Pain, 18 (1), pp. 28-34. , http://dx.doi.org/10.1097/00002508-200201000-00005, PMid:11803300Quesada, G.A.T., Baptista, C.E., Daiana, S.P., Douglas, L.F., Neuralgia Trigeminal-do diagnóstico ao tratamento (2005) Revista Dentística, (11)Siqueira, S.R.D.T., Nóbrega, J.C.M., Valle, L.B.S., Teixeira, M.J., Siqueira, J.T.T., Clinical aspects and dental procedures (2004) Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 98 (3), pp. 311-315Toda, K., Trigeminal neuralgia: Symptoms, diagnosis, classification, and related disorders (2007) Oral Science International, 4 (1), pp. 1-9. , http://dx.doi.org/10.1016/S1348-8643(07)80006-1Tronnier, V.M., Rasche, D., Hamer, J., Treatment of idiopathic trigeminal neuralgia: Comparison of long-term outcome after radiofrequency rhizotomy and microvascular decompression (2001) Neurosurgery, 48, pp. 1261-1268. , PMid:11383728Türp, J.C., Gobetti, J.P., Trigeminal neuralgia versus atypical facial pain: A review of the literature and case report (1996) Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 81 (4), pp. 424-432Yoon, K.B., Wiles, J.R., Miles, J.B., Nurmikko, T.J., Long-term outcome of percutaneous thermocoagulation for trigeminal neuralgia (1999) Anaesthesia, 54 (80), pp. 798-808Yoshimasu, F., Kurland, L.T., Elvelvack, L.R., Tic dolourex in Rochester, Minnesota (1972) Neurology, 22, pp. 952-956. , http://dx.doi.org/10.1212/WNL.22.9.952, 1945-1969. PMid:467338

Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant

Acknowledgements We are grateful for the collaborative work of the reviewers and the entire group of the Observatório COVID-19 BR. In particular, we thank Verônica Coelho for critical inputs. We also thank the research funding agencies: the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil (Finance Code 001 to F.M.D.M., L.S.F. and T.P.P.), Conselho Nacional de Desenvolvimento Científico e Tecnológico—Brazil (grant number: 315854/2020-0 to M.E.B., 141698/2018-7 to R.L.P.S., 313055/2020-3 to P.I.P., 312559/2020-8 to M.A.S.M.V., 311832/2017-2 to R.A.K., 305703/2019-6 to A.A.M.S.) and Fundação de Amparo à Pesquisa do Estado de São Paulo—Brazil (grant number: 2019/26310-2 and 2017/26770-8 to C.F., 2018/26512-1 to O.C., 2018/24037-4 to S.P. and contract number: 2016/01343-7 to R.A.K.). The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers of Disease Control and Prevention.Peer reviewe

Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis

PI3K activation plays a central role in the development of pulmonary inflammation and tissue remodeling. PI3K inhibitors may thus offer an improved therapeutic opportunity to treat non-resolving lung inflammation but their action is limited by unwanted on-target systemic toxicity. Here we present CL27c, a prodrug pan-PI3K inhibitor designed for local therapy, and investigate whether inhaled CL27c is effective in asthma and pulmonary fibrosis. Mice inhaling CL27c show reduced insulin-evoked Akt phosphorylation in lungs, but no change in other tissues and no increase in blood glycaemia, in line with a local action. In murine models of acute or glucocorticoid-resistant neutrophilic asthma, inhaled CL27c reduces inflammation and improves lung function. Finally, inhaled CL27c administered in a therapeutic setting protects from bleomycin-induced lung fibrosis, ultimately leading to significantly improved survival. Therefore, local delivery of a pan-PI3K inhibitor prodrug reduces systemic on-target side effects but effectively treats asthma and irreversible pulmonary fibrosis

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes angiogenesis and ischemia-induced neovascularization via NADPH oxidase 4 (NOX4) and nitric oxide-dependent mechanisms

Background: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has the ability to inhibit angiogenesis by inducing endothelial cell death, as well as being able to promote pro-angiogenic activity in vitro. These seemingly opposite effects make its role in ischemic disease unclear. Using Trail(-/-) and wildtype mice, we sought to determine the role of TRAIL in angiogenesis and neovascularization following hindlimb ischemia. Methods and Results: Reduced vascularization assessed by real-time 3-dimensional Vevo ultrasound imaging and CD31 staining was evident in Trail(-/-) mice after ischemia, and associated with reduced capillary formation and increased apoptosis. Notably, adenoviral TRAIL administration significantly improved limb perfusion, capillary density, and vascular smooth-muscle cell content in both Trail(-/-) and wildtype mice. Fibroblast growth factor-2, a potent angiogenic factor, increased TRAIL expression in human microvascular endothelial cell-1, with fibroblast growth factor-2-mediated proliferation, migration, and tubule formation inhibited with TRAIL siRNA. Both fibroblast growth factor-2 and TRAIL significantly increased NADPH oxidase 4 (NOX4) expression. TRAIL-inducible angiogenic activity in vitro was inhibited with siRNAs targeting NOX4, and consistent with this, NOX4 mRNA was reduced in 3-day ischemic hindlimbs of Trail(-/-) mice. Furthermore, TRAIL-induced proliferation, migration, and tubule formation was blocked by scavenging H2O2, or by inhibiting nitric oxide synthase activity. Importantly, TRAIL-inducible endothelial nitric oxide synthase phosphorylation at Ser-1177 and intracellular human microvascular endothelial cell-1 cell nitric oxide levels were NOX4 dependent. Conclusions: This is the first report demonstrating that TRAIL can promote angiogenesis following hindlimb ischemia in vivo. The angiogenic effect of TRAIL on human microvascular endothelial cell-1 cells is downstream of fibroblast growth factor-2, involving NOX4 and nitric oxide signaling. These data have significant therapeutic implications, such that TRAIL may improve the angiogenic response to ischemia and increase perfusion recovery in patients with cardiovascular disease and diabetes.Belinda Ann Di Bartolo, Siân Peta Cartland, Leonel Prado-Lourenco, Thomas Scott Griffith, Carmine Gentile, Jayant Ravindran, Nor Saadah Muhammad Azahri, Thuan Thai, Amanda Wing Shee Yeung, Shane Ross Thomas, Mary Meltem Kavurm

Search for the standard model Higgs boson in tau final states

We present a search for the standard model Higgs boson using hadronically decaying tau leptons, in 1 inverse femtobarn of data collected with the D0 detector at the Fermilab Tevatron ppbar collider. We select two final states: tau plus missing transverse energy and b jets, and tau+ tau- plus jets. These final states are sensitive to a combination of associated W/Z boson plus Higgs boson, vector boson fusion and gluon-gluon fusion production processes. The observed ratio of the combined limit on the Higgs production cross section at the 95% C.L. to the standard model expectation is 29 for a Higgs boson mass of 115 GeV.Comment: publication versio

Measurement of the ttbar Production Cross Section in ppbar Collisions at sqrt{s} = 1.96 TeV using Kinematic Characteristics of Lepton + Jets Events

We present a measurement of the top quark pair ttbar production cross section in ppbar collisions at a center-of-mass energy of 1.96 TeV using 230 pb**{-1} of data collected by the DO detector at the Fermilab Tevatron Collider. We select events with one charged lepton (electron or muon), large missing transverse energy, and at least four jets, and extract the ttbar content of the sample based on the kinematic characteristics of the events. For a top quark mass of 175 GeV, we measure sigma(ttbar) = 6.7 {+1.4-1.3} (stat) {+1.6- 1.1} (syst) +/-0.4 (lumi) pb, in good agreement with the standard model prediction.Comment: submitted to Phys.Rev.Let

Measurement of the ttbar Production Cross Section in ppbar Collisions at sqrt(s)=1.96 TeV using Lepton + Jets Events with Lifetime b-tagging

We present a measurement of the top quark pair ($t\bar{t}$) production cross section ($\sigma_{t\bar{t}}$) in $p\bar{p}$ collisions at $\sqrt{s}=1.96$ TeV using 230 pb$^{-1}$ of data collected by the D0 experiment at the Fermilab Tevatron Collider. We select events with one charged lepton (electron or muon), missing transverse energy, and jets in the final state. We employ lifetime-based b-jet identification techniques to further enhance the $t\bar{t}$ purity of the selected sample. For a top quark mass of 175 GeV, we measure $\sigma_{t\bar{t}}=8.6^{+1.6}_{-1.5}(stat.+syst.)\pm 0.6(lumi.)$ pb, in agreement with the standard model expectation.Comment: 7 pages, 2 figures, 3 tables Submitted to Phys.Rev.Let

Evidence for a mixed mass composition at the `ankle' in the cosmic-ray spectrum

We report a first measurement for ultra-high energy cosmic rays of the correlation between the depth of shower maximum and the signal in the water Cherenkov stations of air-showers registered simultaneously by the fluorescence and the surface detectors of the Pierre Auger Observatory. Such a correlation measurement is a unique feature of a hybrid air-shower observatory with sensitivity to both the electromagnetic and muonic components. It allows an accurate determination of the spread of primary masses in the cosmic-ray flux. Up till now, constraints on the spread of primary masses have been dominated by systematic uncertainties. The present correlation measurement is not affected by systematics in the measurement of the depth of shower maximum or the signal in the water Cherenkov stations. The analysis relies on general characteristics of air showers and is thus robust also with respect to uncertainties in hadronic event generators. The observed correlation in the energy range around the `ankle' at $\lg(E/{\rm eV})=18.5-19.0$ differs significantly from expectations for pure primary cosmic-ray compositions. A light composition made up of proton and helium only is equally inconsistent with observations. The data are explained well by a mixed composition including nuclei with mass $A > 4$. Scenarios such as the proton dip model, with almost pure compositions, are thus disfavoured as the sole explanation of the ultrahigh-energy cosmic-ray flux at Earth.Comment: Published version. Added journal reference and DOI. Added Report Numbe